# Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease

> **NCT02419872** · — · COMPLETED · sponsor: **Teva Pharmaceuticals Europe** · enrollment: 1743 (actual)

## Conditions studied

- Asthma
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Marketed antagonists

## Key facts

- **NCT ID:** NCT02419872
- **Lead sponsor:** Teva Pharmaceuticals Europe
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-31
- **Primary completion:** 2017-04-07
- **Final completion:** 2017-04-07
- **Target enrollment:** 1743 (ACTUAL)
- **Last updated:** 2017-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02419872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02419872, "Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02419872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*